Advances in Research, Diagnosis, and Treatment of Neuroendocrine Cervical Carcinoma: A Review

IF 3.1 Q2 ONCOLOGY

Oncology Reviews Pub Date : 2023-11-01 DOI:10.3389/or.2023.11764

Xiaoyan Ren, Wenjuan Wu, Qiufan Li, Wen Li, Gang Wang

引用次数: 0

Abstract

Neuroendocrine neoplasms (NENs) were classified separately in the 5th edition (2020) of the World Health Organization (WHO) classification of female genital malignancies. Cervical neuroendocrine carcinoma (NEC) is distinguished by its low incidence, high invasiveness, early local dissemination, and distant metastases. The purpose of this review is to outline the achievements in pathology, diagnostics, gene sequencing, and multi-modality treatment of cervical NEC.

查看原文本刊更多论文

神经内分泌宫颈癌的研究、诊断和治疗进展综述

神经内分泌肿瘤(NENs)在世界卫生组织(WHO)第5版(2020)女性生殖器恶性肿瘤分类中单独分类。宫颈神经内分泌癌(NEC)的特点是低发病率、高侵袭性、早期局部传播和远处转移。这篇综述的目的是概述在病理，诊断，基因测序和多模式治疗宫颈NEC的成就。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Oncology Reviews ONCOLOGY-

CiteScore

6.30

自引率

0.00%

发文量

审稿时长

9 weeks

期刊介绍： Oncology Reviews is a quarterly peer-reviewed, international journal that publishes authoritative state-of-the-art reviews on preclinical and clinical aspects of oncology. The journal will provide up-to-date information on the latest achievements in different fields of oncology for both practising clinicians and basic researchers. Oncology Reviews aims at being international in scope and readership, as reflected also by its Editorial Board, gathering the world leading experts in both pre-clinical research and everyday clinical practice. The journal is open for publication of supplements, monothematic issues and for publishing abstracts of scientific meetings; conditions can be obtained from the Editor-in-Chief or the publisher.